for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Coherus Biosciences Expects Preliminary Unaudited Q1 2020 Net Product Revenue To Be Between $115.0 Mln And $117.5 Mln

April 13 (Reuters) - Coherus BioSciences Inc:

* COHERUS BIOSCIENCES INC - EXPECTS PRELIMINARY UNAUDITED Q1 2020 NET PRODUCT REVENUE TO BE BETWEEN $115.0 MILLION AND $117.5 MILLION

* COHERUS BIOSCIENCES INC - PRELIM UNAUDITED Q1 2020 NET INCOME IS EXPECTED TO BE BETWEEN $33.5 MILLION AND $38.0 MILLION

* COHERUS BIOSCIENCES INC - UDENYCA SAW A 7% UNIT GROWTH IN LAST FOUR WEEKS ENDING MARCH 27, 2020 OVER PREVIOUS FOUR WEEKS Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up